News

The label now indicates hydroxyurea use does not affect benefit received from the medication.

Investigators conducted an educational intervention aimed at strengthening healthcare providers’ readiness to address issues related to medication adherence.

Only 13% of 11,277 pregnant women received the influenza vaccine prior to the 2017 or 2018 influenza seasons.

Up to 91% of the gastroenterologist respondents plan to integrate telehealth into their practice following the COVID-19 pandemic.

In data presented at ACG 2020, researchers show a combination of sulindac and eflornithine could be effective for FAP patients.

Data suggests a more scrutinized follow-up period following surgery.

A review of studies seeks the prevalence, determinants and outcomes of iron deficiency anemia in expecting mothers with sickle cell disease.

Skin pigmentation disorders do not always have a cure or treatment, and they may cause social or emotional burdens for the patient.

A new ACG study shows that 18% would have been considered low risk for NASH-F based on FAST score despite having high liver stiffness measurement.

Girish Hiremath, MD, MPH, discusses a need to more accurately and objectively assess pediatric compliance to eosinophilic esophagitis therapies.

The CDC has standardized guidelines to help diagnose diarrhea, a potential indicator of c. difficile infection.

Female gender, Caucasian race, and older age were all significantly associated with microscopic colitis.

Experts recommend closer follow-up after the surgical removal of pancreatic cysts.

Benjamin Noor, MD, discusses a recent study from ACG that demonstrated that EBTs are associated with improved parameters for weight loss and diabetes.

Tunneled catheters resulted in lower rates of deep vein thrombosis when compared to PICCs.

The findings also showed that large bedded hospitals trended towards higher clostridium difficile infection incidence and mortality rates.

Over the course of the 19 year review, biologic use has increased, while the prevalence of colectomies has decreased.

A new study demonstrates that vedolizumab is associated with real-world corticosteroid-free response and remission in patients with ulcerative colitis and Crohn’s disease.

In a study presented at ACG, investigators find the rate of confirmed HCV infections remained stable pre- and post-interventions.

Brooks Cash, MD, discusses the importance of bowel preparation and surveillance in patients with diabetes.

Anti-TNFs, vedolizumab, ustekinumab, thiopurines, and 5-ASA were all linked to a lower risk of myocardial infarctions.

A poster presented at ACG provides an updated analysis of clostridium difficile infection in the tofacitinib UC clinical program.

Sulindac and eflornithine could help delay the need for lower gastrointestinal surgery for FAP patients.

New data presented at ACG 2020 shows NER1006 bowel preparation to be safe and efficacious in patients with diabetes preparing for their colonoscopy.

Researchers test 3 different doses of mirikizumab in both biologic experienced and naïve Crohn’s disease patients.

An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.

Ustekinumab resulted in a reduction of both stool frequency and rectal bleeding for ulcerative colitis patients.

New research shows patients with chronic liver disease admitted for influenza had an increased risk of disease severity but not a higher odds of mortality.